-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632.O2.6 632. Chronic Myeloid Leukemia: Therapy— Building The Future CML Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, Adult, Diseases, CML, Therapies, Adverse Events, white blood cells, Biological Processes, DNA damage, Technology and Procedures, Cell Lineage, cytogenetics, Study Population, Clinically relevant, Myeloid Malignancies, genomics, Quality Improvement , hematopoiesis, flow cytometry, TKI, NGS
Saturday, December 5, 2020: 7:30 AM-9:00 AM
Moderators:
B. Douglas Smith, MD, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins and Elisabetta Abruzzese, MD , Hematology Unit, S. Eugenio Hospital, Tor Vergata University
Disclosures:
Smith: Jazz: Consultancy, Membership on an entity's Board of Directors or advisory committees; Agios: Consultancy, Membership on an entity's Board of Directors or advisory committees; Celgene: Consultancy, Membership on an entity's Board of Directors or advisory committees; Pfizer: Consultancy, Membership on an entity's Board of Directors or advisory committees; Novartis: Consultancy, Membership on an entity's Board of Directors or advisory committees. Abruzzese: Pfizer: Consultancy, Membership on an entity's Board of Directors or advisory committees; Incyte: Consultancy, Membership on an entity's Board of Directors or advisory committees; Bms: Honoraria; Novartis: Consultancy, Membership on an entity's Board of Directors or advisory committees.
7:30 AM

Itaru Matsumura, MD, PhD1, Shigeki Ohtake, MD, PhD2, Yoshiko Atsuta, MD, PhD3*, Mio Kurata3*, Yosuke Minami, MD, PhD4, Naoto Takahashi, MD, PhD5, Chiaki Nakaseko, MD, PhD6, Noriyoshi Iriyama, MD, PhD7*, Katsumichi Fujimaki, MD8*, Kazuhiko Kakihana, MD, PhD9, Yoji Ogasawara10*, Takaaki ONO, MD, PhD11*, Masaya Okada, MD12*, Tetsuzo Tauchi, MD, PhD13*, Toshihiro Miyamoto, MD, PhD14, Kazunori Ohnishi, MD15, Emiko Sakaida, MD, PhD16, Shin Fujisawa, MD17*, Yukio Kobayashi, MD, DSc18, Norio Asou, MD, PhD19, Hitoshi Kiyoi, MD, PhD20, Yasushi Miyazaki, MD, PhD21 and Tomoki Naoe, MD, PhD22

1Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan
2Kanazawa University, Kanazawa, Japan
3Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
4National Cancer Center Hospital East, Kashiwa, Japan
5Akita University School of Medicine, Akita, Japan
6Department of Hematology, International University of Health and Welfare, Narita, Japan
7Nihon University, Tokyo, Japan
8Fujisawa City Hospital, Fujisawa, Japan
9Department of Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
10Division of Clinical Oncology and Hematology, The Jikei University Hospital, Tokyo, Japan
11Hamamatsu University Hospital, Hamamatsu, Shizuoka, Japan
12Division of Hematology, Department of Internal Medicine, Hyogo College Of Medicine, nishinomiya city, Japan
13Department of Hematology, Tokyo Medical University, Tokyo, Japan
14Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
15Shubun University, Ichinomiya City, Japan
16Department of Hematology, Chiba University Hospital, Chiba City, Japan
17Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
18Hematology Division, IUHW Mita Hospital, Tokyo, Japan
19Department of Hemato-Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan
20Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
21Atomic Bomb Disease Institute, Nagasaki University Hospital, Nagasaki, Japan
22National Hospital Organization, Nagoya Medical Center, Nagoya, Japan

7:45 AM

Tim H Brümmendorf, MD1,2, Jorge E. Cortes, MD3, Dragana Milojkovic4*, Carlo Gambacorti-Passerini, MD5, Richard E. Clark, MA, MD, MRCP, FRCPath6*, Philipp D le Coutre, MD7, Valentín Garcia-Gutiérrez, MD, PhD8, Charles Chuah, MD9, Vamsi Kota, MD3, Jeffrey H. Lipton, MD, PhD10, Philippe Rousselot, MD PhD11*, Michael J. Mauro, MD12, Andreas Hochhaus, MD13, Rafael Hurtado Monroy, MD14, Eric Leip15*, Simon Purcell16*, Anne Yver, PharmD17*, Andrea Viqueira, MD18* and Michael W. Deininger, MD, PhD19

1Dept. of Hematology and Oncology, Center for Integrated Oncology (CIO), Uniklinik RWTH Aachen, Aachen, Germany
2Department of Hematology and Oncology, Center for Integrated Oncology (CIO), Uniklinik RWTH Aachen, Aachen, Germany
3Georgia Cancer Center Augusta University, Augusta, GA
4Department of Haematology, Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom
5Dept of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy
6Department of Haematology, Royal Liverpool University Hospital, Liverpool, United Kingdom
7Charité – Universitätsmedizin Berlin, Berlin, Berlin, Germany
8Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
9Department of Haematology, Singapore General Hospital, Singapore, Singapore
10Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
11Centre Hospitalier de Versailles, Le Chesnay, France
12Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
13Klinik für Innere Medizin II, Jena, Germany
14Head Hematology Department, Hospital Angeles del Pedregal, Mexico, Mexico
15Pfizer Inc., Cambridge, MA
16Pfizer Ltd, London, GBR
17Pfizer Inc, Paris, France
18Pfizer SLU, Madrid, Spain
19Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

8:00 AM

Massimiliano Bonifacio, MD1*, Chiara Elena, MD2*, Mariella D'Adda, MD3*, Luigi Scaffidi, MD1*, Mairi Pucci, MD4*, Fiorenza Aprili4*, Jacqueline Ferrari, MD2*, Alessandra Tucci, MD3*, Fabio Stagno, MD, PhD5, Anna Rita Scortechini, MD6*, Gianni Binotto, MD7*, Mario Annunziata, MD8*, Maria Cristina Miggiano, MD9*, Isabella Capodanno, MD10*, Sara Galimberti, MD, PhD11*, Mario Tiribelli, MD12*, Emilia Giugliano13*, Giovanni Caocci, MD14, Monica Crugnola, MD15*, Paola Ronchi, MD16*, Sabina Russo, MD17*, Martina Tinelli, MD18*, Agostino Tafuri, MD19, Monica Bocchia20*, Alessandra Malato, MD, PhD21*, Mauro Krampera, MD, PhD1, Giuseppe Lippi, MD, PhD4*, Massimo Breccia, MD22*, Giuseppe Saglio, MD, PhD23 and Antonella Gozzini, MD24*

1Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
2Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
3Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
4Department of Neurosciences, Biomedicine and Movement Sciences, Section of Clinical Biochemistry, University of Verona, Verona, Italy
5Hematology Section and BMT Unit, Rodolico Hospital, AOU Policlinico - V. Emanuele, Catania, Catania, Italy
6Division of Hematology, Department of Molecular and Clinical Sciences, Polytechnic University of Marche, Ancona, Italy
7Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padua, Italy
8Hematology Unit, Cardarelli Hospital, Naples, Italy
9Hematology Department, San Bortolo Hospital, Azienda ULSS8 "Berica" di Vicenza, Vicenza, Italy
10Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy
11Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy
12Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
13Division of Internal Medicine and Hematology, San Luigi Gonzaga Hospital, University of Turin, Orbassano (TO), Italy
14Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy
15Hematology and BMT Center, Department of Medicine and Surgery, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
16Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
17Division of Hematology, Policlinico “G. Martino”, University of Messina, Messina, Italy
18Oncology Department, Fracastoro Hospital, Azienda ULSS9 “Scaligera” di Verona, San Bonifacio (VR), Italy
19Hematology Unit, University Hospital Sant'Andrea-Sapienza, Rome, ITA
20Hematology, University of Siena, Siena, Italy
21Department of Hematology, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
22Department of Translational and Precision Medicine, University "Sapienza", Roma, Italy
23Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
24Hematology Unit, AOU Careggi, University of Florence, Florence, ITA

8:15 AM

Jorge E. Cortes, MD1, Jane Apperley, FRCP, FRCPath, MB 2, Andreas Hochhaus, MD3, Michael J. Mauro, MD4, Philippe Rousselot, MD PhD5*, Tomasz Sacha, MD PhD6*, Moshe Talpaz, MD7, Charles Chuah, MD8, Jeffrey H. Lipton, MD, PhD9, Michael W. Deininger, MD, PhD10, Charles A. Schiffer, MD11, Lori J. Maness, MD12, James K. McCloskey, MD13, Valentín García Gutiérrez, MD, PhD14, Hugues de Lavallade, MD, PhD15*, Gabriel Etienne, MD, PhD16*, Vickie Lu, PhD17*, Shouryadeep Srivastava, MBBS, PhD18* and Gianantonio Rosti, MD19*

1Georgia Cancer Center Augusta University, Augusta, GA
2Centre for Haematology, Imperial College, London, United Kingdom
3Jena University Hospital, Jena, Germany
4Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
5Hospital Mignot University de Versailles Saint-Quentin-en-Yvelines, Paris, France
6Department of Hematology, Jagiellonian University Medical College, Krakow, Poland
7Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
8Singapore General Hospital and Duke-NUS Medical School, Singapore, Singapore
9Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
10Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
11Department of Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, MI
12University of Nebraska Medical Center, Omaha, NE
13John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ
14Hematology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
15Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
16Institute Bergonie; Institut National de la Sante et de la Recherche Medicale; Groupe France Intergroupe des Leucemies Myeloides Chroniques, Hopital Haut-Leveque, Pessac, France
17Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
18Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
19University of Bologna, Bologna, Italy

8:30 AM

Naranie Shanmuganathan, FRACP, FRCPA, MBBS1,2,3,4, Carol Wadham, PhD4*, Nur Hezrin Shahrin, PhD4*, Daniel Thomson, PhD, BSc5*, Jinghua Feng, PhD6*, Verity A Saunders2*, Ming Lin6*, Rosalie Kenyon6*, Rob King6*, Paul Wang, PhD6*, David M Ross, MBBS, PhD, FRACP, FRCPA1,2,7,8*, David T Yeung, BSc, PhD, FRACP, FRCPA, MBBS1,2,8, Andreas W Schreiber, PhD6*, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA9,10 and Susan Branford, PhD4,11

1Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
2Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
3Haematology Society of Australia & New Zealand, Sydney, Australia
4Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia
5Department of Genetic and Molecular Pathology, Monash Medical Centre, Melbourne, Australia
6ACRF Cancer Genomics Facility, SA Pathology, Adelaide, Australia
7Department of Haematology, Flinders Medical Centre and University, Adelaide, SA, Australia
8Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
9Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia
10Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
11Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia

8:45 AM

Giorgina Specchia, MD1, Patrizia Pregno2*, Massimo Breccia, MD3*, Chiara Monagheddu4*, Fausto Castagnetti, MD, PhD5,6, Massimiliano Bonifacio, MD7*, Mario Tiribelli, MD8*, Fabio Stagno, MD, PhD9, Giovanni Caocci, MD10, Bruno Martino, MD11*, Luigiana Luciano, MD12, Michele Pizzuti, MD13*, Antonella Gozzini, MD14*, Anna Rita Scortechini, MD15*, Francesco Albano16*, Micaela Bergamaschi, MD17*, Isabella Capodanno, MD18*, Andrea Patriarca, MD19*, Carmen Fava20, Giovanna Rege Cambrin, MD, PhD21*, Federica Sorà, MD22*, Sara Galimberti, MD, PhD23*, Monica Bocchia24*, Gianni Binotto, MD25*, Giovanni Reddiconto26*, Attilio Guarini, MD27*, Alessandro Maggi28*, Grazia Sanpaolo, MD29*, Maria Stella De Candia30*, Valentina Giai, MD, PhD31, Elisabetta Abruzzese, MD 32, Maria Cristina Miggiano, MD33*, Franca Falzetti, MD34*, Gaetano La Barba35*, Giuseppe Pietrantuono36*, Anna Guella, MD37*, Luciano Levato, MD38*, Olga Mulas39*, Fabio Saccona40*, Gianantonio Rosti, MD41*, Pellegrino Musto, MD42, Francesco Di Raimondo, MD43, Fabrizio Pane, MD44, Robin Foà, MD45, Michele Baccarani, MD46, Giovannino Ciccone4* and Giuseppe Saglio, MD, PhD47

1Hematology Section, Department of Emergency and Transplantation - GIMEMA WP CML, University of Bari Aldo Moro, Bari, Italy
2Hematology Unit, Az Ospedaliero Universitaria Città' della Salute e della Scienza, Torino, Italy
3Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
4Unit of Clinical Epidemiology and CPO, Città della Salute Hospital and University, Torino, Italy
5Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
6Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, "S. Orsola-Malpighi" Hospital, Bologna, Italy
7Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
8Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
9Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
10Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy
11Hematology Unit, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
12Hematology Unit, Federico II University of Naples, Napoli, Italy
13Ematologia, Azieda Ospedaliera S. Carlo, Potenza, Italy
14Hematology Unit, AOU Careggi, University of Florence, Florence, ITA
15Division of Hematology, Azienda Ospedaliero Universitaria Ospedali Riuniti Ancona, Ancona, Italy
16University of Bari, Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, Bari, Italy
17Clinical Hematology Unit, IRCCS AOU S.Martino-IST, Genova, Italy
18Hematology Unit, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy
19Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
20Hematology Division, Ospedale Mauriziano, University of Turin, Torino, Italy
21Division of Internal Medicine - Hematology, AUO San Luigi, Orbassano, Italy
22Institute of Hematology, Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, ROMA, Italy
23Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy
24Hematology, University of Siena, Siena, Italy
25Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padua, Italy
26U.O.Hematology Hospital V.Fazzi - Lecce Italy, Lecce, Italy
27Haematology Unit, Istituto Tumori Giovanni Paolo II I.R.C.C.S. Ospedale Oncologico, Bari, Italy
28Hematology, " Giuseppe Moscati" Hospital, Taranto, Italy
29Division of Hematology, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
30Hematology Unit, Ospedale Perrino, Brindisi, Italy
31Università Degli Studi Di Torino, Turin, Turin, Italy
32Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Tor Vergata University, Rome Italy, Rome, Italy
33Hematology Department, San Bortolo Hospital, Vicenza, Italy
34Institute of Hematology, Centro di Ricerche Emato-Oncologiche (CREO), University of Perugia, Perugia, Italy
35Department of Hematology, "Spirito Santo" Hospital, Pescara, ITA
36IRCCS Centro Oncologico Della Basilicata, Rionero In Vulture, ITA
37Ematology section, Ematology section,U.O. Medicina II,Ospedale Santa Chiara, trento, Italy
38Hematology Unit, A. Pugliese Hospital, Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy
39Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
40SCDU Epidemiologia dei Tumori-CPO Piemonte, Az Osp Citta della salute e della Scienza, Turin, Italy
41Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology "L. and A. Seràgnoli", S.Orsola-Malpighi University Hospital, Bologna, Italy
42Hematology and Stem cell Transplantation Unit - Department of Emergency and Organ Transplantation (D.E.T.O.) - University of Bari, Bari, Italy
43Division of Hematology, A.O.U. "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy
44Federico II University of Naples, Hematology Department, Naples, Italy
45Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy
46Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna-GIMEMA WP CML, Institute of Hematology and Medical Oncology "L. & A. Seràgnoli", Bologna, Italy
47Divisione Universitaria di Ematologia e Terapie Cellulari, A.O. Ordine Mauriziano, Turin, Italy

*signifies non-member of ASH